The shakeout in the marijuana sector has been brutal, but the survivors are strong and trade at bargain levels. Read More
Analyst Articles
Earnings are lackluster, valuations are high, trade tensions linger, and leading indicators are weakening. It’s time to get defensive. Read More
Anti-marijuana forces aren’t giving up their efforts to stymie the legalization of weed. But they’re fighting an uphill battle. Read More
We look at the best and worst performing sectors for earnings growth in the fourth quarter. We also examine the S&P 500’s earnings recession. Read More
If your portfolio is properly positioned, you can respond calmly and rationally to unexpected external shocks and sharp downturns. Read More
The contrast in Q4 results between positive revenues and negative earnings is raising questions about net profit margins. Read More
Under the phase one trade deal, China must import considerably more U.S.-grown hemp. That’s good news for cannabis investors. Read More
Boeing's safety woes weigh on the Dow and underscore broader economic and trade problems that could worsen this year. Read More
The bulls are undeterred, despite high valuations and rising risks. That's a bad sign, but here's a correction-proof play. Read More
If certain bills pending in Congress are passed, the marijuana sector could soar. You need to get ahead of the curve. Read More